Coordinating and Data Management Center for Acquired Resistance to Therapy Network
Funded at Roswell Park Cancer Institute Corp · NIH-11413562 · Data updated 2026-11-12
A central center will organize data and resources from a cancer research network focused on how cancers develop resistance to therapy, helping researchers share tools and analyses to advance treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project start | September 1, 2022 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $1,926,317 |
| NIH project number | 5U24CA274159-05 |
| Project ID | NIH-11413562 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not a patient-enrolling study; designed for researchers and institutions working on ARTNet-related cancer resistance research.
✕Less likely to help
Patients with cancer may not directly benefit from participating in this center since it coordinates data and resources rather than enrolling patients.
What this research studies
This grant funds a Coordinating and Data Management Center that will harmonize data from the Acquired Resistance to Therapy Network (ARTNet) and provide centralized infrastructure for collaboration. The center will streamline data acquisition, ensure reproducible analyses, and develop resources that accelerate access to analytical expertise and shared tools for cancer researchers. By fostering communication across investigators and leveraging Bioconductor practices, it aims to translate network findings into strategies to overcome therapy resistance in cancer patients. The work emphasizes data integration, resource sharing, and cross-institutional collaboration to speed scientific progress. It does not involve direct patient enrollment but supports research that could ultimately inform clinical approaches.
Why it matters
Potential benefit: Could accelerate development of effective strategies to overcome acquired resistance to cancer therapies and improve future patient care.
How similar studies have gone: Prior network and data-management centers have shown that centralized coordination and standardized data practices speed translational insights.
Where this research is happening
-
Roswell Park Cancer Institute Corp
Buffalo, United States Active
Researchers
- Principal investigator: Hutson, Alan David — Roswell Park Cancer Institute Corp
- Study coordinator: Hutson, Alan David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.